mscard report: P12

Baseline T1 to follow-up T4, interval 3.16 years. Lesion masks: supplied. mscard 0.1.0, lesiontrack 0.2.0, generated 2026-09-29 17:44 UTC.
Research software, not a medical device. Nothing on this page is a diagnosis. Every number below is produced by an open pipeline and, where a coloured badge is shown, the same pipeline was run on this subject's own baseline scan with known changes injected, and the badge says how well it recovered them. A green badge means the number can be read at face value on this scan; amber, read it together with the calibration table; red, the pipeline could not recover that kind of change here and the number should not be used.

Findings

13
new lesions (+1 adjacent fragments)
masks supplied: detection is the annotator's, not graded
5
enlarging lesions
calibration: 0 of 28 baseline lesions falsely called changed
8
shrinking lesions
calibration: 0 of 28 baseline lesions falsely called changed
9
resolved lesions
calibration: 0 of 28 baseline lesions falsely called resolved
5.7 %/yr
lesion volume change (29.55 to 34.88 ml)
calibration: 0 of 28 baseline lesions falsely called changed
39
slowly expanding lesion candidates
calibration: 92 candidates with no true expansion
-1.84 %/yr
brain volume change (deformation field)
calibration: -2.0 % injected, -2.3 % measured
2.81 %/yr
brain volume change (mask ratio)
not graded

Brain volume change is the mean Jacobian determinant over the baseline brain mask. Its boundary check repeats the mean with the mask eroded 6 mm: -5.82 % full against -5.90 % eroded over the interval (disagreement 0.03 points per year: green ≤ 0.5, amber ≤ 1.5, red beyond). A change confined to the outer rim is rim-dominated: a mask difference between the two visits, or cortical change the eroded mask leaves out; the calibration cannot separate the two because a synthetic follow-up is stripped identically.

Baseline: 32 lesions, 29.55 ml. Classes follow Vanden Bulcke et al. 2025 bands: enlarging or shrinking beyond ±9 %/yr, stable within ±4 %/yr, trend between (2 trend up, 2 trend down, 0 stable). SEL candidates are the Elliott et al. 2019 Jacobian rule; a definite SEL is a cohort-relative ranking and needs a cohort.

How this report was graded

The baseline scan of this subject was turned into a synthetic follow-up one modelled year later: the whole brain contracted by -2.0 %, 12 new lesions (27 to 1507 mm³) placed at least 6 mm from every existing lesion, a rigid repositioning (-0.12, 0.96, 0.00 degrees; -0.36, -0.50, -0.63 voxels), gains 0.95, 0.92 and 2 % noise. Every baseline lesion moves with the field and nothing else; its truth volume in the synthetic mask is recorded per lesion, so each enlarging, shrinking or resolved call is judged against that lesion's own truth. The same pipeline then measured baseline against this synthetic scan.

Report lineTruthPipeline reportedReading
New lesions12 injected12 reported (12 new, 0 adjacent fragment); 0 false new, 4 false fragments; largest missed –not graded (sensitivity 1.00)
False new lesions00not graded
Enlarging or shrinking calls on baseline lesions16 of 28 truly beyond ±9 %/yr0 false (0.0 %), 0 missed; class agreement 1.00read at face value
Resolved calls on baseline lesions0 of 280read at face value
SEL candidates on baseline lesions092 (2.88 per baseline lesion)not trustworthy here
Brain volume change-2.00 %-2.27 % from the deformation field (recovery 1.13); -1.76 % from the mask ratio (recovery 0.88)read at face value

Injected lesions reported by size: <50 mm³: 3 of 3; 50-150 mm³: 3 of 3; 150-400 mm³: 2 of 2; >=400 mm³: 4 of 4.

Bands (mscard's own, stated so you can disagree): new-lesion sensitivity green ≥ 0.9, false new ≤ 1, brain-volume recovery [0.8, 1.2], false change rate ≤ 0.05, false resolved ≤ 0.0, SEL candidates per lesion ≤ 0.2; amber up to the second value of each.

Images

Real pair, baseline T1 to T4: baseline lesions (cyan), new voxels on the warped follow-up (yellow), Jacobian expansion inside lesions with SEL candidate outlines (lime).

overview_T4.png

Calibration pair, baseline to synthetic follow-up, same rendering.

overview_SYN.png

Lesions

GroupClassBaseline mm³Follow-up mm³%/yrVoxel centre (halfway grid)
2trend_up16689189944.461, 122, 93
12enlarging74131116416.0121, 140, 87
14trend_up295733784.5118, 54, 88
15shrinking989307-21.8108, 155, 110
3enlarging10115416.648, 120, 52
31new0115–84, 62, 108
11shrinking156107-9.979, 71, 41
1enlarging507918.444, 97, 61
17shrinking12057-16.6108, 113, 124
40new055–143, 119, 89
18shrinking11553-17.1107, 138, 133
20trend_down6050-5.3107, 122, 128
9shrinking17148-22.879, 139, 133
7shrinking11642-20.256, 143, 79
24enlarging93694.9120, 75, 106
6shrinking10434-21.360, 98, 125
10trend_down3732-4.375, 110, 132
34new031–92, 126, 38
23shrinking8928-21.7115, 108, 119
37new028–126, 152, 97
28new022–68, 150, 108
33new019–86, 155, 78
21enlarging10139.5110, 62, 101
29adjacent_fragment09–78, 69, 37
27new08–63, 80, 59
32new04–83, 127, 38
39new04–129, 117, 47
30new04–78, 167, 77
35new04–100, 80, 70
38new02–128, 120, 43
36new01–103, 49, 78
8resolved290-31.666, 156, 103
13resolved140-31.6101, 68, 39
22resolved10-31.6111, 93, 119
16resolved780-31.6107, 125, 121
25resolved430-31.6126, 71, 113
4resolved900-31.650, 94, 81
19resolved310-31.6108, 77, 119
5resolved520-31.654, 64, 98
26resolved210-31.6130, 70, 78

Method